303 related articles for article (PubMed ID: 30053318)
1. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.
Cai C; Zeng W; Wang H; Ren S
Int J Chron Obstruct Pulmon Dis; 2024; 19():933-943. PubMed ID: 38646605
[TBL] [Abstract][Full Text] [Related]
3. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
[TBL] [Abstract][Full Text] [Related]
4. Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Liao QQ; Mo YJ; Zhu KW; Gao F; Huang B; Chen P; Jing FT; Jiang X; Xu HZ; Tang YF; Chu LW; Huang HL; Wang WL; Wei FN; Huang DD; Zhao BJ; Chen J; Zhang H
Int J Chron Obstruct Pulmon Dis; 2024; 19():501-518. PubMed ID: 38414718
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic roles of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, C-reactive protein, and cancer antigen 125 for ovarian cancer.
Ye L; Zhou G; Zhou L; Wang D; Xiong S; Liu C; Zhang G
J Int Med Res; 2023 Dec; 51(12):3000605231218557. PubMed ID: 38130127
[TBL] [Abstract][Full Text] [Related]
6. Associations of circulating immunomarkers with the efficacy of immunotherapy for primary hepatic carcinoma.
Liu S; Xu W; Shu H; Dai Y; Du Y; Liu Y; Huang L; Sun G
Cancer Med; 2023 Dec; 12(24):21830-21848. PubMed ID: 38054365
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)-A Retrospective Single Center Study and a Literature Review.
Mireștean CC; Stan MC; Iancu RI; Iancu DPT; Bădulescu F
Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998532
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Utility of NLR, PLR and MLR in Early Diagnosis of Gastric Cancer: an Analytical Cross-Sectional Study.
Karra S; Gurushankari B; Rajalekshmy MR; Elamurugan TP; Mahalakshmy T; Kate V; Nanda N; Rajesh NG; Shankar G
J Gastrointest Cancer; 2023 Dec; 54(4):1322-1330. PubMed ID: 37198382
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index on short- and long-term outcome following surgery for spinal metastases.
Ryvlin J; Kim SW; Hamad MK; Fourman MS; Eleswarapu A; Murthy SG; Gelfand Y; De la Garza Ramos R; Yassari R
J Neurosurg Spine; 2024 Apr; 40(4):475-484. PubMed ID: 38157531
[TBL] [Abstract][Full Text] [Related]
10. Postpartum Depression and Inflammatory Biomarkers of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio: A Prospective Observational Study.
La Verde M; Luciano M; Fordellone M; Sampogna G; Lettieri D; Palma M; Torella D; Marrapodi MM; Di Vincenzo M; Torella M
Gynecol Obstet Invest; 2024; 89(2):140-149. PubMed ID: 38346412
[TBL] [Abstract][Full Text] [Related]
11. Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients.
Chong W; Zhang Z; Luo R; Gu J; Lin J; Wei Q; Li B; Myers R; Lu-Yao G; Kelly WK; Wang C; Yang H
BMC Cancer; 2021 Jun; 21(1):655. PubMed ID: 34078304
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non-small cell lung cancer undergoing stereotactic body radiotherapy.
Fang F; Jia Z; Xie H; Cao Y; Zhu X; Yang XY; Guo X; Zhang H
Clin Respir J; 2024 May; 18(5):e13749. PubMed ID: 38685745
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment inflammatory biomarkers in patients with laryngeal cancer.
Kawano T; Hirano T; Tateyama K; Yoshinaga K; Shinomura K; Suzuki M
Asian J Surg; 2024 May; 47(5):2144-2151. PubMed ID: 38311505
[TBL] [Abstract][Full Text] [Related]
14. Can preoperative neutrophil to lymphocyte, lymphocyte to monocyte, or platelet to lymphocyte ratios differentiate glioblastoma from brain metastasis?
Baran O; Kemerdere R; Korkmaz TS; Kayhan A; Tanriverdi T
Medicine (Baltimore); 2019 Dec; 98(50):e18306. PubMed ID: 31852112
[TBL] [Abstract][Full Text] [Related]
15. Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis.
Tian T; Wei B; Wang J
BMC Emerg Med; 2021 Jul; 21(1):81. PubMed ID: 34233608
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu-PSMA-617.
Şahin E; Kefeli U; Zorlu Ş; Seyyar M; Ozkorkmaz Akdag M; Can Sanci P; Karakayali A; Ucuncu Kefeli A; Bakkal Temi Y; Cabuk D; Uygun K
Medicine (Baltimore); 2023 Nov; 102(47):e35843. PubMed ID: 38013293
[TBL] [Abstract][Full Text] [Related]
17. An analysis of neutrophil-to-lymphocyte ratios and monocyte-to-lymphocyte ratios with six-month prognosis after cerebral contusions.
Zhang D; Zhuang D; Li T; Liu X; Zhang Z; Zhu L; Tian F; Chen X; Li K; Chen W; Sheng J
Front Immunol; 2024; 15():1336862. PubMed ID: 38545111
[TBL] [Abstract][Full Text] [Related]
18. Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer.
Moukas SI; Kasimir-Bauer S; Tewes M; Kolberg HC; Hoffmann O; Kimmig R; Keup C
Sci Rep; 2023 Dec; 13(1):21262. PubMed ID: 38040730
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Hemoglobin Level With New Inflammatory Markers in the Emergency Department: A Retrospective Study Exploring Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte, and Mean Platelet Volume-to-Platelet Count Ratios.
Hassan M; Abdayem C; El Daouk S; Matar BF
Cureus; 2024 Mar; 16(3):e55401. PubMed ID: 38562344
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of The Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Platelet Count for Platinum-Sensitive Recurrent Epithelial Ovarian Cancer.
Sowannakul A; Rodpenpear N; Ekbhum P; Tantitamit T
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3765-3771. PubMed ID: 38019234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
